Cleared Traditional

K122019 - STREPTOCOCCUS APP. SEROLOGICAL REAGENTS (FDA 510(k) Clearance)

Sep 2012
Decision
65d
Days
Class 1
Risk

K122019 is an FDA 510(k) clearance for the STREPTOCOCCUS APP. SEROLOGICAL REAGENTS. This device is classified as a Group A Streptococcus Nucleic Acid Amplification Assay System (Class I - General Controls, product code OYZ).

Submitted by Meridian Bioscience, Inc. (Cincinnati, US). The FDA issued a Cleared decision on September 13, 2012, 65 days after receiving the submission on July 10, 2012.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3740. An In Vitro Diagnostic Test For The Detection Of Streptococcuc Pyogenes (group A Beta Hemolytic Streptococcus) In Throat Swab Specimens From Symptomatic Patients..

Submission Details

510(k) Number K122019 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 10, 2012
Decision Date September 13, 2012
Days to Decision 65 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code OYZ — Group A Streptococcus Nucleic Acid Amplification Assay System
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3740
Definition An In Vitro Diagnostic Test For The Detection Of Streptococcuc Pyogenes (group A Beta Hemolytic Streptococcus) In Throat Swab Specimens From Symptomatic Patients.